Owing to the limited sample size of patients in our study, further investigations are needed to confirm these findings and establish the role of PGK1 and GRP78 as a reliable clinical predictor for endometrial carcinoma outcomes. The gene discussed is PGK1; the disease is endometrial carcinoma.